Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 5.52% | 58.61 | 0.0% | $1744.69m | |
| GILD | Gilead Sciences, Inc. | -0.27% | 75.12 | 1.0% | $1314.92m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.67% | 582.10 | 2.5% | $967.82m | |
| AMGN | Amgen, Inc. | -0.22% | 223.63 | 1.3% | $644.89m | |
| NVAX | Novavax, Inc. | 0.36% | 45.00 | 102.0% | $581.79m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.26% | 278.11 | 1.9% | $546.14m | |
| BIIB | Biogen, Inc. | -0.01% | 300.47 | 1.6% | $410.35m | |
| ILMN | Illumina, Inc. | -1.72% | 366.61 | 3.5% | $382.50m | |
| SRNE | Sorrento Therapeutics, Inc. | 0.41% | 4.97 | 1.8% | $298.90m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.57% | 116.22 | 2.0% | $269.23m | |
| SGEN | Seattle Genetics, Inc. | -0.08% | 151.43 | 6.1% | $254.30m | |
| A | Agilent Technologies, Inc. | 0.58% | 87.19 | 1.6% | $200.66m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.26% | 104.27 | 4.3% | $177.51m | |
| CODX | Co-Diagnostics, Inc. | -0.60% | 17.37 | 0.0% | $169.88m | |
| INCY | Incyte Corp. | -0.46% | 100.09 | 2.5% | $156.77m |
Company Profile
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA.